// App-Quantinova.ai

BSH19‐EP‐074 : A Case of Acquired Haemophilia secondary to Atypical Carcinoid Tumour

Researchers

Presenter

  • N. Prasannan

Principal Investigators

  • B. Chatterjee

  • J. Pasi

  • V. McDonald

  • W. Maposa

  • W. Ricketts

  • K. Lau

  • K. Giaslakiotis

  • A. Ocansey

  • L. Bowles

  • D. Hart

Medical Centers

  • Haemophilia, The Royal London Hospital, Haemophilia Centre, Barts Health NHS Trust

  • Respiratory medicine

  • Cardiothoracics, Barts Thorax Centre, Barts Health NHS Trust

  • Haematology, Royal London Hospital Bart's Health Trust, London

  • Barts Thorax Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

Disease

  • Hemophilia

  • Intestinal carcinoid tumor

Biomarkers

  • 18F-fluorodeoxyglucose

  • Proliferation marker protein Ki-67

  • Activated partial thromboplastin time

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • Rituximab

  • FVIII

  • IVIG

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved